Interventional Oncology Market Worth $1.5 Billion by 2025, Growing at a CAGR of 7.7% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®

    NEXT STORY
    Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
    PREV STORY
    Tiziana Life Sciences PLC Directorate Change
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal

    author_avatar
    NASDAQ Market News

    Sensus Healthcare Announces CME Presentation by Dr. Jeffrey S. Fromowitz Today at the Fall Clinical Virtual Grand Rounds Series

    author_avatar
    NASDAQ Market News

    Dextera Surgical’s MicroCutter Technology Highlighted at Annual Meeting of the German Society for Thoracic Surgery

    FREIBURG, Germany, Sept. 27, 2016 (GLOBE NEWSWIRE) -- Dextera Surgical Inc. (Nasdaq:DXTR), manufacturer of ...

    author_avatar
    NASDAQ Market News